BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15471130)

  • 1. Gamna Gandy bodies of spleen seen in CML: a causal association--a case report.
    Varma D; Khurana N; Singh T
    Indian J Pathol Microbiol; 2004 Jan; 47(1):51-2. PubMed ID: 15471130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the splenic vein diameter and longitudinal size of the spleen in patients with Gamna-Gandy bodies.
    Unsal NH; Erden A; Erden I
    Diagn Interv Radiol; 2006 Sep; 12(3):125-8. PubMed ID: 16972216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamna-Gandy bodies of the spleen detected with MR imaging: a case report.
    Dobritz M; Nömayr A; Bautz W; Fellner FA
    Magn Reson Imaging; 2001 Nov; 19(9):1249-51. PubMed ID: 11755737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behcet's disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature.
    Vaiopoulos G; Terpos E; Viniou N; Nodaros K; Rombos J; Loukopoulos D
    Am J Hematol; 2001 Jan; 66(1):57-8. PubMed ID: 11426495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Education and imaging. Hepatobiliary and pancreatic: Gamna-Gandy bodies of the spleen.
    Yilmaz S; Yekeler E; Rozanes I
    J Gastroenterol Hepatol; 2007 May; 22(5):758. PubMed ID: 17444868
    [No Abstract]   [Full Text] [Related]  

  • 6. Gamna-Gandy bodies: a sign of portal hypertension.
    Selçuk D; Demirel K; Kantarci F; Mihmanli I; Oğüt G
    Turk J Gastroenterol; 2005 Sep; 16(3):150-2. PubMed ID: 16245226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composition and significance of splenic Gamna-Gandy bodies in sickle cell anemia.
    Piccin A; Rizkalla H; Smith O; McMahon C; Furlan C; Murphy C; Negri G; Mc Dermott M
    Hum Pathol; 2012 Jul; 43(7):1028-36. PubMed ID: 22079355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gamna Gandy bodies: Features mimicking a mycotic disease. Two cases in the spleen].
    Ambrosetti D; Lassalle S; N'Golet A; Lazzarotto-Rumpler M; Hofman P
    Ann Pathol; 2006 Sep; 26(4):271-4. PubMed ID: 17128154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible leg ulcer due to hydroxyurea in a case of chronic myeloid leukemia.
    Tripathi AK; Ahmad R; Sawlani KK
    J Assoc Physicians India; 2003 Oct; 51():1014-5. PubMed ID: 14719596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamna-Gandy bodies of the spleen: evaluation with MR imaging.
    Sagoh T; Itoh K; Togashi K; Shibata T; Nishimura K; Minami S; Asato R; Noma S; Fujisawa I; Yamashita K
    Radiology; 1989 Sep; 172(3):685-7. PubMed ID: 2672093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid resolution of portal vein thrombosis and noncirrhotic portal hypertension following cyto-reductive therapy in a patient with chronic myeloid leukemia.
    Ince AT; Bölükbaş C; Dalay R; Sökmen HM; Kurdaş OO
    Turk J Gastroenterol; 2003 Jun; 14(2):141-4. PubMed ID: 14614643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamna-Gandy bodies.
    Bernaerts A; Vanhoenacker FM; Op de Beeck B; De Schepper AM
    JBR-BTR; 2001; 84(5):202. PubMed ID: 11757677
    [No Abstract]   [Full Text] [Related]  

  • 13. Gangrene of the toes in a patient with chronic myelogenous leukemia after long-term hydroxyurea therapy.
    Leo E; Krämer A; Hochhaus A; Krasniqi F; Hehlmann R; Ho AD
    Ann Hematol; 2002 Aug; 81(8):467-9. PubMed ID: 12224005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perimalleolar ulcers in hydroxyurea treated patients with concomitant chronic venous disease: diagnostic pitfalls.
    Jain V; Gupta K; Nagpal N
    J Coll Physicians Surg Pak; 2005 Oct; 15(10):658-60. PubMed ID: 19810313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraplegia as the presenting manifestation of extramedullary megakaryoblastic transformation of previously undiagnosed chronic myelogenous leukemia.
    Bryant BJ; Alperin JB; Elghetany MT
    Am J Hematol; 2007 Feb; 82(2):150-4. PubMed ID: 17019692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of drug-induced colitis complicating the administration of hydroxycarbamide.
    Sadamoto Y; Ueda T; Matsumoto M; Kubokawa M; Ito K; Kubo H; Tanaka M; Harada N; Muta K; Nawata H; Takata M; Yao T
    Endoscopy; 2002 Jun; 34(6):511. PubMed ID: 12048644
    [No Abstract]   [Full Text] [Related]  

  • 18. [Leg ulcer due to hydroxyurea. A case report].
    Gning SB; Debonne JM; Diagne-Guèye NM; Ndiaye B; Fall F; Mbaye PS
    Dakar Med; 2006; 51(2):89-91. PubMed ID: 17632983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical correlates of submicroscopic deletions involving the ABL-BCR translocation region in chronic myeloid leukemia.
    Yoong Y; VanDeWalker TJ; Carlson RO; Dewald GW; Tefferi A
    Eur J Haematol; 2005 Feb; 74(2):124-7. PubMed ID: 15654903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
    Kometani K; Aoki M; Kawamata S; Shinozuka Y; Era T; Taniwaki M; Hattori M; Minato N
    Cancer Res; 2006 Oct; 66(20):9967-76. PubMed ID: 17047059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.